Recent 52-Week High Exceeded in Shares of Gilead Sciences (GILD)
Gilead Sciences (NASDAQ:GILD) traded today at a new 52-week high of $77.32. This new high was reached on below average trading volume as 3.7 million shares traded hands, while the average 30-day volume is approximately 10.5 million shares.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company's primary arees of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.
Gilead Sciences share prices have moved between a 52-week high of $77.32 and a 52-week low of $21.91 and are now trading 251% above that low price at $76.89 per share. The 200-day and 50-day moving averages have moved 0.64% higher and 0.24% higher over the past week, respectively.
Potential upside of 18.5% exists for Gilead Sciences, based on a current level of $76.89 and analysts' average consensus price target of $91.08. Gilead Sciences shares have support at the 50-day moving average (MA) of $72.34 and additional support at the 200-day MA of $61.31.
SmarTrend recommended that subscribers consider buying shares of Gilead Sciences on September 9th, 2013 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $61.87. Since that recommendation, shares of Gilead Sciences have risen 21.6%. We continue to monitor GILD for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: 52 week high/lows Gilead Sciences